PA8 CLINICAL STUDY OF THE EFFECTIVENESS OF THE DIET WITHOUT GLUTEN AND CASEIN AND ANTI-INFLAMMATORY INTESTINAL CHANGING BOWEL AND PSYCHIATRIC SYMPTOMS IN PATIENTS WITH INFANTILE AUTISM. STUDY AND PRELIMINARY RESULTS

2009 ◽  
Vol 41 ◽  
pp. S225
Author(s):  
M. Brunero ◽  
P. Bailo ◽  
R. Boldorini
2018 ◽  
Vol 108 (6) ◽  
pp. 1156-1162 ◽  
Author(s):  
Lisa Örtqvist ◽  
Hedvig Engberg ◽  
Anna Strandqvist ◽  
Anna Nordenström ◽  
Gundela Holmdahl ◽  
...  

Ensho ◽  
1984 ◽  
Vol 4 (4) ◽  
pp. 531-534
Author(s):  
Sachiko Sugawara ◽  
Hiroko Ohno ◽  
Reiko Ueda ◽  
Miyako Ishigami ◽  
Daiya Kubodera ◽  
...  

2000 ◽  
Vol 24 (2) ◽  
pp. 163-168 ◽  
Author(s):  
J. E. Sanders ◽  
J. M. Greve ◽  
C. Clinton ◽  
B. J. Hafner

Interface stresses and stump shape were measured during sessions over a twomonth interval on a transtibial amputee subject. Results from thirteen transducer sites monitored during four sessions showed greater interface pressure changes over time at anterior sites than at lateral or posterior locations. There was a trend of decreased pressure with stump swelling and increased pressure for stump atrophy. During one session in which stump shape was monitored over a 23.1 min interval after ambulation, stump swelling was localised. Swelling tended to increase in the regions of initial enlargement, as opposed to redistributing through different areas over time. Regions of swelling were anterior lateral and posterior proximal, areas of thick underlying soft tissue. Identification of localised areas of swelling and atrophy and understanding of their effects on interface pressures could be used to improve individual socket design.


1989 ◽  
Vol 75 (3) ◽  
pp. 257-258 ◽  
Author(s):  
Maria Teresa Nobile ◽  
Maria Giuseppina Vidili ◽  
Marco Benasso ◽  
Marco Venturini ◽  
Michele Tedeschi ◽  
...  

Reduced glutathione (GSH) has been reported to be an effective protector against cyclophosphamide-induced urotoxicity in experimental models, providing protection comparable to that of mesna. This paper describes our preliminary results of the clinical use of GSH in combination with cyclophosphamide. GSH was administered i.v. in two divided doses of 2.5 g, 15 min before and 30 min after escalating doses of cyclophosphamide ranging from 1.2 up to 1.6 g/m2 (1-h infusion). GSH was well tolerated and did not produce unexpected toxicity. The lack of bladder damage, including microscopic hematuria, supports the protective role of this thiol compound.


Sign in / Sign up

Export Citation Format

Share Document